Apraglutide is under clinical development by Ironwood Pharmaceuticals and currently in Phase III for Short Bowel Syndrome.
IBA venture PanTera gains €134m in funding to scale up actinium-225 production – Pharmaceutical Technology
PanTera aims to accelerate actinium-225 production, used in promising targeted alpha therapy for cancer. Image: Getty Images / Love Employee. PanTera, a Belgian radioisotope producer,